Subtype identification and functional characterization of ryanodine receptors in rat cerebral artery myocytes.
Ryanodine receptors (RyRs) regulate contractility in resistance-size cerebral artery smooth muscle, yet their molecular identity, subcellular location, and phenotype in this tissue remain unknown. Following rat resistance-size cerebral artery myocyte sarcoplasmic reticulum (SR) purification and incorporation into POPE-POPS-POPC (5:3:2; wt/wt) bilayers, unitary conductances of 110 +/- 8, 334 +/- 15, and 441 +/- 27 pS in symmetric 300 mM Cs(+) were usually detected. The most frequent (34/40 bilayers) conductance (334 pS) decreased to <or=100 pS when Cs(+) was replaced with Ca(2+). The predominant conductance displayed 66 bursts/min with at least three open and three closed states. The steady-state activity (NP(o))-voltage curve was bell shaped, with NP(o) drastically decreasing when voltage was switched from -30 to -40 mV. NP(o) increased when intracellular calcium (Ca(2+)(i)) was raised within 0.1-100 microM to abruptly diminish with higher Ca(2+)(i). Thus maximal activity occurred within the Ca(2+)(i) range found in rat cerebral artery myocytes under physiological conditions. NP(o) was reduced by ruthenium red (80 muM), increased monotonically by caffeine (0.1-5 mM) or ryanodine (0.05-5 microM), and unaffected by heparin (2 mg/ml). This phenotype resembles that of cardiac RyR and recombinant RyR2. RT-PCR detected RyR1, RyR2, and RyR3 transcripts in cerebral artery myocytes. However, real-time PCR indicated that RyR2 was 4 and 1.5 times more abundant than RyR1 and RyR3, respectively. Consistently, Western blotting showed that the RyR2 product was very abundant. Immunofluorescence showed that each RyR isoform distributed differentially among subcellular compartments. In particular, RyR2 was drastically stronger in the subplasmalemma than in other compartments, underscoring the predominance of RyR2 in a compartment where SR is abundant. Consistently, RyR from SR-enriched membranes displayed pharmacological specificity typical of RyR2, being activated by digoxin (1 muM), resistant to dantrolene (100 muM), and shifted to a subconductance by neomycin (100 nM). Therefore, RyR2 is the predominant molecular and functional RyR that is expressed in the SR membrane of rat resistance-size cerebral artery myocytes.
Vaithianathan
Thirumalini
T
Department Pharmacology, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA.
Narayanan
Damodaran
D
Asuncion-Chin
Maria T
MT
Jeyakumar
Loice H
LH
Liu
Jianxi
J
Fleischer
Sidney
S
Jaggar
Jonathan H
JH
Dopico
Alejandro M
AM
D000818:Animals; D002478:Cells, Cultured; D002536:Cerebral Arteries / Q000737:chemistry / Q000166:cytology* / Q000502:physiology*; D005260:Female; D008297:Male; D032342:Muscle Cells / Q000737:chemistry / Q000502:physiology*; D021122:Protein Subunits / Q000032:analysis / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D019837:Ryanodine Receptor Calcium Release Channel / Q000032:analysis / Q000502:physiology*
D021122:Protein Subunits; D019837:Ryanodine Receptor Calcium Release Channel
Mol Pharmacol. 2007 Aug;72(2):359-69
17468198
Trends Neurosci. 1988 Oct;11(10):453-7
2469164
Am J Physiol Heart Circ Physiol. 2001 Jan;280(1):H208-15
11123235
Neurocrit Care. 2009;10(1):93-102
18923817
Anesthesiology. 1996 Jun;84(6):1368-79
8669678
Annu Rev Biophys Biophys Chem. 1989;18:333-64
2660829
J Cell Biol. 1999 Nov 29;147(5):995-1008
10579720
Am J Physiol Heart Circ Physiol. 2001 Mar;280(3):H1201-7
11179064
Am J Physiol Heart Circ Physiol. 2001 May;280(5):H2399-405
11299247
Am J Physiol Cell Physiol. 2003 Jun;284(6):C1468-80
12570985
Biophys J. 1989 Mar;55(3):415-24
2539209
Mol Pharmacol. 2003 Aug;64(2):365-72
12869641
Acta Physiol Scand. 1998 Dec;164(4):577-87
9887980
J Vasc Res. 2004 May-Jun;41(3):229-40
15118362
Am J Physiol Cell Physiol. 2003 Apr;284(4):C999-C1005
12477664
Cell Calcium. 2008 Aug;44(2):190-201
18191199
Am J Physiol Cell Physiol. 2001 Dec;281(6):C1769-75
11698234
J Physiol. 2006 Jan 1;570(Pt 1):5-11
16195319
J Biol Chem. 2002 Nov 1;277(44):41778-85
12213830
J Biol Chem. 2002 May 3;277(18):15801-6
11842082
Int Rev Cytol. 1998;183:185-270
9666568
Biochem Biophys Res Commun. 1995 Oct 24;215(3):814-21
7488046
Biophys J. 1999 Aug;77(2):808-16
10423427
Biochem Biophys Res Commun. 2004 Oct 1;322(4):1280-5
15336975
J Biol Chem. 1989 Oct 5;264(28):16776-85
2550460
Circ Res. 2001 Nov 23;89(11):1051-7
11717163
J Biol Chem. 1989 Jan 15;264(2):1329-35
2463249
Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):18217-22
15604147
J Gen Physiol. 2003 Nov;122(5):583-603
14581584
J Gen Physiol. 2004 Apr;123(4):377-86
15024040
Am J Physiol Cell Physiol. 2000 Feb;278(2):C235-56
10666018
Front Biosci. 2002 May 01;7:d1212-1222
11991852
J Physiol. 1991 Aug;439:463-80
1716676
Biophys J. 1994 Oct;67(4):1484-94
7819484
Trends Pharmacol Sci. 1994 May;15(5):145-9
7754532
Am J Physiol. 1987 Sep;253(3 Pt 1):C364-8
2443015
J Biol Chem. 1989 Jan 25;264(3):1715-22
2536370
Biophys J. 2002 Apr;82(4):1953-63
11916853
J Mol Biol. 2004 Apr 30;338(3):533-45
15081811
Cell Biochem Biophys. 2004;40(2):207-24
15054223
Cell Calcium. 2003 Sep;34(3):211-29
12887969
Circ Res. 2001 Jun 8;88(11):1151-8
11397781
Biochem Biophys Res Commun. 2008 Apr 25;369(1):195-207
18182155
FEBS Lett. 1993 Oct 4;331(3):223-7
8397110
Am J Physiol. 1994 Jun;266(6 Pt 1):C1485-504
8023884
Biophys J. 2003 Feb;84(2 Pt 1):942-59
12547776
Am J Physiol Cell Physiol. 2007 Jun;292(6):C2122-8
17314264
J Biol Chem. 1998 Jun 26;273(26):16011-20
9632651
Science. 1995 Oct 27;270(5236):633-7
7570021
Science. 1998 Aug 7;281(5378):818-21
9694652
J Muscle Res Cell Motil. 2002;23(4):285-92
12630702
Front Biosci. 2002 Nov 01;7:d2072-80
12438018
Mol Pharmacol. 1996 Jan;49(1):40-8
8569710
Cell Calcium. 2004 Feb;35(2):165-77
14706290
Biophys J. 2004 Dec;87(6):3814-25
15361409
Physiol Rev. 2002 Oct;82(4):893-922
12270947
Am J Physiol Heart Circ Physiol. 2006 Mar;290(3):H1136-44
16227345
Am J Physiol Cell Physiol. 2000 Nov;279(5):C1528-39
11029300
J Cell Biol. 1981 Sep;90(3):577-94
6974735
Cell Calcium. 2005 Sep-Oct;38(3-4):253-60
16115682
Cell Calcium. 2007 Oct-Nov;42(4-5):447-66
17629940
Circ Res. 2005 Dec 9;97(12):1270-9
16269659
J Gen Physiol. 2005 Mar;125(3):253-5
15738047
J Gen Physiol. 2000 May;115(5):653-62
10779321
J Gen Physiol. 1999 Feb;113(2):229-38
9925821
Pflugers Arch. 2003 Mar;445(6):665-73
12632186
Biophys J. 2002 Jun;82(6):3037-47
12023226
Biochem Biophys Res Commun. 2001 Mar 9;281(4):979-86
11237759
J Biol Chem. 1998 Jun 12;273(24):14675-8
9614063
Annu Rev Biochem. 2007;76:367-85
17506640
J Bioenerg Biomembr. 1991 Aug;23(4):537-60
1917908
J Gen Physiol. 2008 Jul;132(1):13-28
18562499
J Physiol. 1998 Apr 1;508 ( Pt 1):211-21
9490841
FEBS Lett. 1995 Jun 19;367(1):23-7
7541372
Am J Physiol Lung Cell Mol Physiol. 2005 Aug;289(2):L338-48
15863441
Am J Physiol Cell Physiol. 2008 Nov;295(5):C1376-84
18799650
Biophys J. 1998 Nov;75(5):2302-12
9788925
Pharmacol Rev. 1997 Mar;49(1):1-51
9085308
Br J Pharmacol. 2008 Mar;153 Suppl 2:S1-209
18347570
Clin Exp Pharmacol Physiol. 1997 Dec;24(12):989-92
9406674
Clin Exp Pharmacol Physiol. 2008 Sep;35(9):1121-6
18215181
News Physiol Sci. 2004 Jun;19:138-47
15143210
Biophys J. 1998 May;74(5):2352-64
9591662
J Physiol. 2007 Oct 1;584(Pt 1):205-19
17673505
Ann N Y Acad Sci. 1998 Sep 16;853:130-48
10603942